周度策略行业配置观点：无法复刻的广场协议之下，杠铃权重再审视-20250630

Key Insights - The report highlights the ongoing "stagflation" risk in the US economy, with the first quarter of 2025 showing a contraction in GDP of -0.5%, indicating a technical recession, while core PCE inflation remains sticky at 3.5% [9] - The approval of the first stablecoin license for a Chinese brokerage firm signals a shift in regulatory stance towards stablecoins, emphasizing their strategic value for cross-border payments [9][8] - Xiaomi's YU7 model has seen overwhelming demand, with over 289,000 orders within an hour of launch, raising concerns about production capacity and potential legal risks in secondary markets [9][8] Industry Analysis Fluorochemicals - The quota system driven by policy has led to a rigid freeze on the production capacity of third-generation refrigerants, accelerating the exit of smaller players and allowing leading companies to gain pricing power, pushing refrigerant prices upward [17] - The supply of fluorite resources is constrained due to low extraction ratios and stricter environmental policies, further solidifying cost support [17] Innovative Pharmaceuticals - The innovative pharmaceutical sector is experiencing a phase of adjustment, primarily influenced by emotional factors and trading dynamics, with valuations returning to near five-year lows, presenting an entry opportunity for investors [18] - The export transaction volume of domestic innovative drugs reached $45.5 billion from January to May 2025, contributing positively to profits [18] Semiconductors - The semiconductor market is witnessing a recovery in risk appetite, with the AI industry chain potentially becoming a focal point again [18] - External technological restrictions and geopolitical risks are driving the localization of supply chains, with increasing domestic production rates for semiconductor equipment and materials [18]